Acute Mask Effects on Walk Distance and Vital Signs
INVESTIGATION of the ACUTE EFFECT of MASK USE on WALKING DISTANCE and VITAL SIGNS DURING the INCREMENTAL SHUTTLE WALK TEST in HEALTHY INDIVIDUALS
1 other identifier
observational
30
0 countries
N/A
Brief Summary
The goal of this prospective observational study is to investigate the acute effects of mask use on walking distance and vital signs in healthy individuals aged 18-24 years. The main questions it aims to answer are: Does wearing a mask affect walking distance during the Incremental Shuttle Walk Test (ISWT)? How does mask use influence heart rate, oxygen saturation, blood pressure, and respiratory rate during the test? Researchers will compare participants performing the ISWT with a mask to those performing it without a mask to determine any differences in walking distance and vital signs. Participants will: Complete the ISWT twice: once with a mask and once without a mask, on separate days. Have their heart rate, oxygen saturation, respiratory rate, blood pressure, and dyspnea perception measured before and after each test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2024
CompletedFirst Posted
Study publicly available on registry
October 9, 2024
CompletedStudy Start
First participant enrolled
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedOctober 15, 2024
October 1, 2024
4 months
October 8, 2024
October 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Heart rate
Heart rate will be evaluated using a heart rate monitor (Polar FT 100).
Before the test and immediately after the test
Oxygen saturation
Oxygen saturation will be evaluated with a portable pulse oximeter.
Before the test and immediately after the test
Blood pressure
Blood pressure will be evaluated by sphygmomanometer.
Before the test and immediately after the test
Respiratory frequency
Respiratory frequency will be evaluated by counting the number of breaths in a minute, and dyspnea perception was evaluated using the Modified Borg Scale.
Before the test and immediately after the test
Dyspnea perception
Dyspnea perception will be evaluated using the Modified Borg Scale.
Before the test and immediately after the test
Study Arms (2)
Masked Group
Participants who performed the Incremental Shuttle Walk Test (ISWT) while wearing a face mask.
Unmasked Group
Participants who performed the Incremental Shuttle Walk Test (ISWT) without wearing a face mask.
Interventions
Participants were recommended to wear comfortable clothing and appropriate shoes for the test. To minimize variability, one masked and one unmasked ISWT was performed on the same participant at the same time of day, one day apart
Eligibility Criteria
The study population consists of healthy volunteers, aged between 18 and 24 years, with a body mass index (BMI) of less than 30 kg/m². All participants are free from any known chronic or acute diseases, do not take prescription medications (except for oral contraception), and have no history of drug, alcohol, or cigarette use. Additionally, participants with blood pressure greater than 160/100 mmHg or those with known pregnancy status are excluded from the study.
You may qualify if:
- Individuals aged 18-24 years.
- Body mass index of less than 30 kg/m².
- No known diseases
You may not qualify if:
- Individuals with a self-reported history of chronic or acute disease/dysfunction that contraindicates or limits participation in exercise testing.
- Individuals taking prescription medications other than oral contraception.
- Those with known pregnancy status.
- Individuals who use drugs, cigarettes, or alcohol.
- Individuals with blood pressure greater than ≥160/100 mmHg.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nagihan Acetlead
Related Publications (7)
Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992 Dec;47(12):1019-24. doi: 10.1136/thx.47.12.1019.
PMID: 1494764BACKGROUNDProbst VS, Hernandes NA, Teixeira DC, Felcar JM, Mesquita RB, Goncalves CG, Hayashi D, Singh S, Pitta F. Reference values for the incremental shuttle walking test. Respir Med. 2012 Feb;106(2):243-8. doi: 10.1016/j.rmed.2011.07.023. Epub 2011 Aug 23.
PMID: 21865021BACKGROUNDParreira VF, Janaudis-Ferreira T, Evans RA, Mathur S, Goldstein RS, Brooks D. Measurement properties of the incremental shuttle walk test. a systematic review. Chest. 2014 Jun;145(6):1357-1369. doi: 10.1378/chest.13-2071.
PMID: 24384555BACKGROUNDBurdon JG, Juniper EF, Killian KJ, Hargreave FE, Campbell EJ. The perception of breathlessness in asthma. Am Rev Respir Dis. 1982 Nov;126(5):825-8. doi: 10.1164/arrd.1982.126.5.825.
PMID: 7149447BACKGROUNDGrant S, Aitchison T, Henderson E, Christie J, Zare S, McMurray J, Dargie H. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest. 1999 Nov;116(5):1208-17. doi: 10.1378/chest.116.5.1208.
PMID: 10559077BACKGROUNDWu G, Sanderson B, Bittner V. The 6-minute walk test: how important is the learning effect? Am Heart J. 2003 Jul;146(1):129-33. doi: 10.1016/S0002-8703(03)00119-4.
PMID: 12851620BACKGROUNDGoncalves CG, Mesquita R, Hayashi D, Merli MF, Vidotto LS, Fernandes KB, Probst VS. Does the Incremental Shuttle Walking Test require maximal effort in healthy subjects of different ages? Physiotherapy. 2015 Jun;101(2):141-6. doi: 10.1016/j.physio.2014.11.002. Epub 2014 Nov 11.
PMID: 25700634BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Murat Esmer
Gazi University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
October 8, 2024
First Posted
October 9, 2024
Study Start
October 15, 2024
Primary Completion
February 15, 2025
Study Completion
March 1, 2025
Last Updated
October 15, 2024
Record last verified: 2024-10